


Healthcare Industry NewsFeed
HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
HSMN NewsFeed - 22 Dec 2015
SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
HSMN NewsFeed - 22 Dec 2015
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
HSMN NewsFeed - 21 Dec 2015
Axonics Modulation Technologies Announces $38.5 Million Series B Financing
Axonics Modulation Technologies Announces $38.5 Million Series B Financing
HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
HSMN NewsFeed - 18 Dec 2015
ARIAD Names Paris Panayiotopoulos as Its President and Chief Executive Officer
ARIAD Names Paris Panayiotopoulos as Its President and Chief Executive Officer
HSMN NewsFeed - 17 Dec 2015
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
HSMN NewsFeed - 17 Dec 2015
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
